• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

WHO Defends Voluntary Blood Donation Policy

November 21, 2013

In a recent commentary in Science, Neelam Dhingra, on behalf of the World Health Organization (WHO), defended their voluntary non-rumunerated blood donation (VNRBD) policy. Current WHO VNRBC policy allows for small rewards, such as a free cholesterol screening. Lacetera and colleagues previously challenged VNRBDs suggesting that increased economic rewards such as a lottery ticket or other items below minimum wage can motivate more individuals to donate blood. However, Dhingra argues that increased incentives to donate blood could exploit the underprivileged and compromise the blood supply. Furthermore, Dhingra emphasized decisions about public health policies such as VNRBD need to include “equality, transferability, acceptability, patient preferences, and social values” in addition to data from randomized controlled trials. In a rebuttal letter to Dhingra’s commentary, Lacetera stressed that “these debates benefit from the availability of relevant empirical evidence that includes the use of representative samples, actual donation behavior using standard collection procedures, and causally identified short- and long-term effects on both donations and safety.” The WHO stands by its policy of VNRBD and believes that future policy forums should focus on strengthening voluntary blood donations.

References

1.    Dhingra N. In defense of WHO’s blood donation policy. Science;342: 691-2.

2.    Lacetera N, Macis M, Slonim R. In defense of WHO’s blood donation policy–response. Science;342: 692.

Filed Under

  • Blood Donation
  • News
  • Policy and Guidelines
  • Quality Control and Regulatory

Recommended

  • Leukoreduction Alone May Be Sufficient to Prevent Transfusion-Transmitted Cytomegalovirus Infection in Preterm Infants

  • Chagas Disease Screening for Family Members of Positive Blood Donors

  • Recommendations for Patient Blood Management in Adults

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley